Corpus Intelligence DCF — ARKANSAS VALLEY REGL MED CTR 2026-04-26 14:14 UTC
DCF — ARKANSAS VALLEY REGL MED CTR
Enterprise Value: $-33.5M
🛡️ Public data only — no PHI permitted on this instance.
$-33.5M
Enterprise Value
$-11.2M
PV of Cash Flows
$-22.3M
PV of Terminal Value
$-36.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth

Cash Flow Projections

PROJ
YearRevenueEBITDAMarginFCFPV(FCF)
Year 1$38.2M$-1.8M-5.0%$-3.4M$-3.1M
Year 2$39.3M$-1.4M-4.0%$-3.1M$-2.6M
Year 3$40.5M$-1.1M-3.0%$-2.8M$-2.1M
Year 4$41.7M$-0.9M-2.0%$-2.7M$-1.8M
Year 5$43.0M$-0.8M-2.0%$-2.6M$-1.6M

Interpretation

INT

At a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-33.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.

Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.

Assumptions

ASSM
revenue base$37.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.051464272527643365
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5